EE9800134A - Farmatseutiline kompositsioon intravenoosseks manustamiseks - Google Patents

Farmatseutiline kompositsioon intravenoosseks manustamiseks

Info

Publication number
EE9800134A
EE9800134A EE9800134A EE9800134A EE9800134A EE 9800134 A EE9800134 A EE 9800134A EE 9800134 A EE9800134 A EE 9800134A EE 9800134 A EE9800134 A EE 9800134A EE 9800134 A EE9800134 A EE 9800134A
Authority
EE
Estonia
Prior art keywords
pharmaceutical composition
intravenous administration
administration
composition
tonicity
Prior art date
Application number
EE9800134A
Other languages
English (en)
Other versions
EE03518B1 (et
Inventor
M. Gelotte Karl
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603721.3A external-priority patent/GB9603721D0/en
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of EE9800134A publication Critical patent/EE9800134A/et
Publication of EE03518B1 publication Critical patent/EE03518B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EE9800134A 1995-10-27 1996-10-23 Farmatseutiline kompositsioon ja selle kasutamine EE03518B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US590795P 1995-10-27 1995-10-27
GBGB9603721.3A GB9603721D0 (en) 1996-02-22 1996-02-22 Composition for inhibiting platelet aggregation
PCT/US1996/017193 WO1997015328A1 (en) 1995-10-27 1996-10-23 Pharmaceutical compositions containing platelet aggregation inhibitors

Publications (2)

Publication Number Publication Date
EE9800134A true EE9800134A (et) 1998-10-15
EE03518B1 EE03518B1 (et) 2001-10-15

Family

ID=26308777

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800134A EE03518B1 (et) 1995-10-27 1996-10-23 Farmatseutiline kompositsioon ja selle kasutamine

Country Status (35)

Country Link
EP (1) EP0859634B1 (et)
JP (1) JP3452367B2 (et)
KR (1) KR100362799B1 (et)
CN (1) CN1158107C (et)
AT (1) ATE213648T1 (et)
AU (1) AU712755B2 (et)
BG (1) BG63623B1 (et)
BR (1) BR9610878A (et)
CA (1) CA2234364C (et)
CO (1) CO4770960A1 (et)
CY (1) CY2292B1 (et)
CZ (1) CZ290381B6 (et)
DE (1) DE69619540T2 (et)
DK (1) DK0859634T3 (et)
DZ (1) DZ2110A1 (et)
EA (1) EA000628B1 (et)
EE (1) EE03518B1 (et)
ES (1) ES2171749T3 (et)
HK (1) HK1017846A1 (et)
HU (1) HU228757B1 (et)
IL (1) IL123790A (et)
IS (1) IS1948B (et)
MX (1) MX9803275A (et)
MY (1) MY116837A (et)
NO (1) NO324415B1 (et)
NZ (1) NZ323134A (et)
PL (1) PL185744B1 (et)
PT (1) PT859634E (et)
SA (1) SA96170527B1 (et)
SI (1) SI0859634T1 (et)
SK (1) SK282353B6 (et)
TR (1) TR199800716T2 (et)
TW (1) TW385248B (et)
UA (1) UA45423C2 (et)
WO (1) WO1997015328A1 (et)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ633900A0 (en) 2000-03-20 2000-04-15 Jurox Pty Ltd Anaesthetic composition
CN1322863C (zh) * 2004-10-29 2007-06-27 武汉远大制药集团股份有限公司 一种抑制血小板凝聚的注射液及其制备方法
CN100386079C (zh) * 2005-03-24 2008-05-07 武汉远大制药集团股份有限公司 一种抑制血小板凝聚的注射用粉针及其制备方法
CN100367961C (zh) * 2005-09-30 2008-02-13 天津南开允公医药科技有限公司 盐酸替罗非班冻干粉针注射剂及其制备方法
CN102125519B (zh) * 2011-02-28 2012-07-11 正大青春宝药业有限公司 稳定的盐酸替罗非班注射液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931441A (en) * 1988-11-09 1990-06-05 Luitpold Pharmaceuticals, Inc. Stabilized aqueous leucovorin calcium compositions
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
UA45423C2 (uk) 2002-04-15
DE69619540T2 (de) 2002-08-22
HU228757B1 (en) 2013-05-28
EE03518B1 (et) 2001-10-15
NZ323134A (en) 1999-11-29
IS1948B (is) 2004-10-13
SA96170527B1 (ar) 2005-12-21
EA199800336A1 (ru) 1998-10-29
BG63623B1 (bg) 2002-07-31
CZ127898A3 (cs) 1998-10-14
CO4770960A1 (es) 1999-04-30
EP0859634B1 (en) 2002-02-27
NO981869D0 (no) 1998-04-24
KR100362799B1 (ko) 2003-07-16
CY2292B1 (en) 2003-07-04
PL326419A1 (en) 1998-09-14
KR19990067020A (ko) 1999-08-16
WO1997015328A1 (en) 1997-05-01
CZ290381B6 (cs) 2002-07-17
BR9610878A (pt) 1999-07-13
PT859634E (pt) 2002-07-31
MX9803275A (es) 1998-09-30
SK282353B6 (sk) 2002-01-07
IS4699A (is) 1998-03-24
JP3452367B2 (ja) 2003-09-29
TR199800716T2 (xx) 1998-07-21
TW385248B (en) 2000-03-21
DZ2110A1 (fr) 2002-07-22
ATE213648T1 (de) 2002-03-15
JPH10512296A (ja) 1998-11-24
DK0859634T3 (da) 2002-03-25
HUP9902521A3 (en) 2000-01-28
EP0859634A1 (en) 1998-08-26
IL123790A0 (en) 1998-10-30
CN1158107C (zh) 2004-07-21
HUP9902521A2 (hu) 1999-12-28
CA2234364A1 (en) 1997-05-01
AU7718996A (en) 1997-05-15
NO324415B1 (no) 2007-10-08
SK51298A3 (en) 1998-12-02
ES2171749T3 (es) 2002-09-16
CA2234364C (en) 2000-02-08
AU712755B2 (en) 1999-11-18
MY116837A (en) 2004-04-30
HK1017846A1 (en) 1999-12-03
EA000628B1 (ru) 1999-12-29
SI0859634T1 (en) 2002-04-30
PL185744B1 (pl) 2003-07-31
DE69619540D1 (de) 2002-04-04
BG102405A (en) 1999-08-31
CN1200676A (zh) 1998-12-02
IL123790A (en) 2001-11-25
NO981869L (no) 1998-04-24

Similar Documents

Publication Publication Date Title
NO963053D0 (no) Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav
HUP0004076A2 (hu) C-4"-Szubsztituált-makrolid-származékok
DE69328192D1 (de) Injizierbare Arzneizubereitungen enthaltend Taxanderivate
MY100343A (en) Amide derivative and external medicament comprising same
KR900006318A (ko) 피페리디닐 벤즈이미다졸
ES482782A1 (es) Un procedimiento para la preparacion de derivados de imida- zol
EE9800134A (et) Farmatseutiline kompositsioon intravenoosseks manustamiseks
DE69132578D1 (de) Cephemderivate
HUP9800631A2 (hu) 4-Amino-tetrahidrobenzizoxazol- és 4-amino-tetrahidrobenzizotiazol-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk gyógyszerkészítmények előállítására
HUP9802736A2 (hu) 1,4-Dihidropiridin-származékok alkalmazása artériafal ateroszklerózisos degradálódásának megelőzésére és gyógyítására alkalmas gyógyszerkészítmény előállítására
NZ246598A (en) Trazodone derivatives; compounds and preparation, pharmaceutical compositions; intermediate compounds
GB1313228A (en) Tri-iodo-benzoic acid derivatives
IT1161210B (it) Metodo per modulare la risposta immunitaria con dibenzocicloeptenilideni
IL71068A (en) N-(3-trifluoromethylphenyl)-n'-propargyl-piperazine,its preparation and pharmaceutical compositions containing it
FI860098A0 (fi) Nya piperazinderivat, foerfarande foer deras framstaellning och farmaceutiska kompositioner som innehaoller dessa foereningar som aktiv ingrediens.
KR900014360A (ko) 피리딘카복실산 아미드 유도체 및 이를 함유하는 약학 조성물
ATE29133T1 (de) Troponon-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
ATE21908T1 (de) Derivate von 1,4-diaminocyclitol, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
BG103985A (en) Multicyclic derivatives of erythromycin
ATE228359T1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
GB1384441A (en) Benzomorphan derivatives
GB1463965A (en) Pharmaceutical compositions containing benzylamines
KR940014408A (ko) 신규 세팔로스포린계 항생제(ii)
IL116557A0 (en) Antiherpes peptidomimetic compounds their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231

GB1A Change in the ownership or in the address of the owner
MM4A Lapsed by not paying the annual fees

Effective date: 20141023